a Department of Internal Medicine, Harvard Medical School , Boston , MA , USA.
b NSF International , Ann Arbor , MI , USA.
Clin Toxicol (Phila). 2019 Feb;57(2):125-130. doi: 10.1080/15563650.2018.1497171. Epub 2018 Sep 6.
Higenamine is a stimulant with cardiovascular properties recently prohibited in sport by the World Anti-Doping Agency (WADA). Higenamine is also a natural constituent of several traditional botanical remedies and is listed as an ingredient in weight loss and sports supplements sold over-the-counter in the United States.
We analyzed dietary supplements available for sale in the United States prior to WADA's prohibition of higenamine in sport for the presence and quantity of higenamine.
All supplements labeled as containing higenamine or a synonym (i.e., norcoclaurine or demethylcoclaurine) available for sale in the United States were identified. For each brand, one sample was analyzed by NSF International (Ann Arbor, MI) and one sample by the Netherland's National Institute for Public Health and the Environment (RIVM). NSF International carried out qualitative and quantitative analyses using ultra high performance liquid chromatography (UHPLC) with tandem mass spectrometry. RIVM carried out qualitative analysis using UHPLC quadrupole time of flight mass spectrometry for an independent confirmation of identity.
Twenty-four products were analyzed. The majority of supplements were marketed as either weight loss (11/24; 46%) or sports/energy supplements (11/24; 46%); two brands did not list a labeled indication. The quantity of higenamine (±95% CI) ranged from trace amounts to 62 ± 6.0 mg per serving. Consumers could be exposed to up to 110 ± 11 mg of higenamine per day when following recommended serving sizes provided on the label. Five products (5/24; 21%) listed an amount of higenamine, but none were accurately labeled; the quantity in these supplements ranged from <0.01% to 200% of the quantity listed on the label.
Dosages of up to 62 ± 6.0 mg per serving of the stimulant higenamine were found in dietary supplements sold in the United States.
盐酸育亨宾是一种具有心血管特性的兴奋剂,最近被世界反兴奋剂机构(WADA)禁止在运动中使用。盐酸育亨宾也是几种传统植物疗法的天然成分,并被列为美国非处方销售的减肥药和运动补充剂的成分之一。
在 WADA 禁止盐酸育亨宾在运动中使用之前,我们分析了美国市场上销售的膳食补充剂中盐酸育亨宾的存在和含量。
确定了所有在美国销售的标签上含有盐酸育亨宾或同义词(即去甲育亨宾或去甲基育亨宾)的补充剂。每个品牌的样本由 NSF International(密歇根州安阿伯)和荷兰国家公共卫生与环境研究所(RIVM)各分析一份。NSF International 使用超高效液相色谱(UHPLC)串联质谱法进行定性和定量分析。RIVM 使用 UHPLC 四极杆飞行时间质谱法进行定性分析,以独立确认身份。
分析了 24 种产品。大多数补充剂被标记为减肥药(11/24;46%)或运动/能量补充剂(11/24;46%);两个品牌没有列出标签指示。盐酸育亨宾的含量(±95%CI)范围从痕量到 62±6.0mg/份。消费者按照标签上推荐的食用量,每天可能会摄入高达 110±11mg 的盐酸育亨宾。有 5 种产品(5/24;21%)列出了盐酸育亨宾的含量,但都没有准确标记;这些补充剂中的含量范围从标签上列出的含量的 <0.01%到 200%不等。
在美国销售的膳食补充剂中,每一份的兴奋剂盐酸育亨宾含量高达 62±6.0mg。